Brought to you by:
Search Results for PTFE grafts
PTFE crural bypasses: ‘Very acceptable patency, excellent limb salvage is obtainable with a fairly aggressive approach’
“The mantra I always use with fellows is bad vein, bad bypass.” Those were the words of Gregg Landis, MD, system chief of vascular surgery at Northwell Health in New York, as he presented an 18-year experience of polytetrafluoroethylene (PTFE)…
New paradigm in arteriovenous grafts opens up possibility of novel cure for diabetes
A novel twist to arteriovenous graft platforms—traditionally the preserve of hemodialysis—has the ability to open up a new paradigm of treatment across a host of metabolic disorders like diabetes, a study to be presented at a scientific session on June…
Changing gears: A guide to cruising back to the operating room
For surgeons-in-training, professional development time (colloquially known as “the research years”) is a welcome break from the rigors of surgical residency. A time to rest, reflect, and embark on new growth opportunities. A reprieve from the 6:00 a.m. (or earlier)…
Trust, transportation, insurance hamper ‘quality vascular surgery care for all,’ Crawford Forum hears
An absence of patient trust in their doctors and hospital systems yesterday morning emerged as a key talking point amid a comprehensive deep dive into some of the problems vascular surgeons tackle in their efforts to broaden access to quality…
Fusion Bioline vascular graft demonstrates improved patency rates and reduced time to hemostasis
This advertorial is sponsored by Getinge. Alan Lumsden, MD, Jean Panneton, MD, and Hiranya Rajasinghe, MD, detail the hemostatic and minimally thrombogenic benefits of the Fusion Bioline vascular graft. With a heparin-bonded luminal vessel surface of minimally thrombotic polytetrafluoroethylene (PTFE)…
Interim results of covered stent-graft hint at ‘new avenue’ in dialysis access treatment
The interim results of a first-in-human trial of a sirolimus-eluting covered stent graft—Solaris DE (Solaris Endovascular)—for the treatment of dialysis access dysfunction demonstrate the promise of the device in treating vascular access outflow stenosis, an investigator in the trial has…
Gore announces MDR expanded indication for the Viabahn VBX balloon-expandable endoprosthesis as a bridging stent
Gore today announced CE-mark approval of an expanded indication for the Gore Viabahn VBX balloon-expandable endoprosthesis (VBX stent graft) when used as a bridging stent with branched and fenestrated aortic endografts in the treatment of aortic aneurysms involving the renal…
Research suggests arm vein is the best alternative bypass conduit to GSV in patients with CLTI
A new analysis has found arm vein to be the most suitable alternative conduit to great saphenous vein (GSV) in chronic limb-threatening ischemia (CLTI) patients, particularly in below-knee bypass targets. Prosthetic grafts also represent an adequate option, the researchers add,…
Why 25 years of patient-centered innovation really matters
This advertorial is sponsored by Gore. One mainstay endovascular aneurysm repair (EVAR) device is celebrating not just a quarter century of being commercially available, but the innovation it has inspired along the way. Michel Makaroun, MD, and Willy Davison, PhD,…
First patient enrolled in Wrapsody endoprosthesis registry study
Merit Medical has announced the successful enrollment of the first patient in its WRAP registry study in a press release. The study will evaluate the clinical benefits associated with the use of the Wrapsody cell-impermeable endoprosthesis in patients receiving hemodialysis…